Comparison of Hepatic Resection And Transarterial Chemoembolization For UICC Stage T3 Hepatocellular Carcinoma: A Propensity Score Matching Study
from BMC Cancer
From June 14:
BACKGROUND: The optimal therapeutic strategy in UICC stage T3 hepatocellular carcinoma (HCC) patients that maximizes both safety and long-term outcome has not yet been determined. Our aim was to compare clinical outcomes following hepatic resection (HR) versus transarterial chemoembolization (TACE) for stage T3 HCC. METHODS: From 2005 to 2013, 1179 patients with T3 HCC who underwent HR or TACE were divided into two groups, HR group (n = 280) or TACE group (n = 899). The clinical outcomes were compared before and after propensity score matching.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063